Glenmark Pharmaceuticals Limited — Others, 25-04-2025: Shareholders meeting

Glenmark Pharmaceuticals has reported the results of its recent Postal Ballot conducted via remote e-voting. The shareholders approved three special resolutions, including the appointment of Mr. Pradeep Kumar Sinha as a Non-Executive Independent Director and the re-appointments of Mr. Rajesh Desai and Mr. Dipankar Bhattacharjee as Independent Directors, with significant majorities. However, a resolution regarding the reappointment of Mr. Rajesh Desai was not passed, receiving only 70.32% approval, below the required majority. This outcome reflects strong shareholder engagement but also highlights areas of concern that may influence investor sentiment regarding Board composition decisions.